Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07137559) titled 'CELZ-201-DDT for the Treatment of Chronic Lower Back Pain' on Aug. 14.
Study Type: Expanded Access
Primary Sponsor: Creative Medical Technology Holdings Inc
Condition:
Chronic Back Pain
Degenerative Disc Disease Lumbar
Intervention:
Drug: CELZ-201-DDT
Recruitment Status: Not recruiting
Date of First Enrollment: May 1, 2024
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07137559
Published by HT Digital Content Services with permission from Health Daily Digest....